Mr. Jim Hutchens reports

IMAGIN MEDICAL ANNOUNCES STOCK OPTIONS GRANTED

Pursuant to Imagin Medical Inc.'s stock option plan, an aggregate of 2.25 million shares have been granted to certain directors, officers and consultants as incentive stock options at an exercise price of 18 cents per share. The options are exercisable for a period of five years, ending on Oct. 26, 2022.

About Imagin Medical Inc.

Imagin Medical is developing imaging solutions for minimally invasive surgical procedures where endoscopes are used. The company believes it will radically improve the way physicians detect cancer and view the surgical field. Imagin's initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the United States, and the most costly cancer to treat due to a greater-than-50-per-cent recurrence rate. The ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.

We seek Safe Harbor.